Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
iShares MSCI South Africa ETF
EZA
$560M
| $3.61M | ﹤0.01% |
86,250
+58,326
| +209% | +$2.8M |
|
4477
State Street SPDR S&P Capital Markets ETF
KCE
$480M
| $3.61M | ﹤0.01% |
26,247
-10,569
| -29% | -$1.46M |
|
4478
CALL
Bio-Rad Laboratories Class A
BIO
$9.53B
| $3.61M | ﹤0.01% |
11,000
+2,600
| +31% | +$883K |
|
4479
Graphic Packaging
GPK
$3.38B
| $3.61M | ﹤0.01% |
133,013
+132,892
| +109,828% | +$3.84M |
|
4480
Skywest
SKYW
$4.18B
| $3.61M | ﹤0.01% |
36,073
-60,940
| -63% | -$6.22M |
|
4481
United States Lime & Minerals
USLM
$3.37B
| $3.61M | ﹤0.01% |
27,204
+22,877
| +529% | +$2.9M |
|
4482
Encore Capital Group
ECPG
$2.2B
| $3.61M | ﹤0.01% |
75,521
+30,288
| +67% | +$1.44M |
|
4483
CALL
QuantumScape Corp
QS
$3.81B
| $3.6M | ﹤0.01% |
694,000
+87,500
| +14% | +$459K |
|
4484
PUT
Onto Innovation
ONTO
$20.3B
| $3.6M | ﹤0.01% |
21,600
+6,600
| +44% | +$1.21M |
|
4485
PUT
Birkenstock
BIRK
$7B
| $3.59M | ﹤0.01% |
63,400
-28,900
| -31% | -$1.47M |
|
4486
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $3.59M | ﹤0.01% |
70,160
+5,307
| +8% | +$282K |
|
|
APLS
4487
DELISTED
Apellis Pharmaceuticals
APLS
| $3.59M | ﹤0.01% |
112,423
-85,710
| -43% | -$2.58M |
|
4488
CALL
Chemours
CC
$2.39B
| $3.59M | ﹤0.01% |
212,200
-3,700
| -2% | -$72K |
|
4489
NBT Bancorp
NBTB
$2.78B
| $3.59M | ﹤0.01% |
75,072
+56,686
| +308% | +$2.7M |
|
|
EMBJ
4490
Embraer S.A. ADS
EMBJ
$13.4B
| $3.59M | ﹤0.01% |
97,744
+29,617
| +43% | +$1.07M |
|
4491
PUT
Q2 Holdings
QTWO
$4.04B
| $3.58M | ﹤0.01% |
35,600
+27,500
| +340% | +$2.61M |
|
4492
CALL
Eastman Chemical
EMN
$8.47B
| $3.58M | ﹤0.01% |
39,200
-16,400
| -29% | -$1.68M |
|
4493
Hims & Hers Health
HIMS
$6.57B
| $3.58M | ﹤0.01% |
147,955
-1,724,217
| -92% | -$42.7M |
|
4494
CALL
Northern Trust
NTRS
$35B
| $3.58M | ﹤0.01% |
34,900
-131,600
| -79% | -$13.5M |
|
4495
Apple Hospitality REIT
APLE
$3.79B
| $3.57M | ﹤0.01% |
+232,894
| New | +$3.61M |
|
4496
CALL
Ventas
VTR
$46.9B
| $3.57M | ﹤0.01% |
60,700
-77,800
| -56% | -$4.89M |
|
4497
CALL
American Financial Group
AFG
$12.1B
| $3.57M | ﹤0.01% |
26,100
+12,800
| +96% | +$1.76M |
|
4498
Fox Class B
FOX
$25.8B
| $3.57M | ﹤0.01% |
78,122
-24,746
| -24% | -$1.04M |
|
4499
NETGEAR
NTGR
$656M
| $3.57M | ﹤0.01% |
128,194
-56,153
| -30% | -$1.32M |
|
4500
Fulton Financial
FULT
$4.72B
| $3.57M | ﹤0.01% |
185,285
+179,386
| +3,041% | +$3.51M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.